Skip to main content
. 2021 Jan 8;10:586752. doi: 10.3389/fonc.2020.586752

Figure 1.

Figure 1

EBER ISH and immunohistochemistry results of immune markers in gastric cancer (×20). EBER ISH-negative (A) and EBER ISH-positive (B) cases. Representative images of CD3+ T lymphocytes (C) CD68+ macrophage (D) CD20+ B lymphocyte cells (E) and CD57+ NK cells (F) and expression levels of HER2 (G) and PCNA (H) in gastric cancer tissues.